Article · 26 Feb 2026
PerspectivePublished 14 Jul 2016
Developability assessment as an early de-risking tool for biopharmaceutical development
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Increasing attrition of therapeutic candidates during preclinical and clinical development affects productivity and causes spiraling costs, negatively impacting the development of new treatments. For biopharmaceuticals, product design, lead selection and manufacturing process development constitute significant areas of risk because of their decisive influence on product quality, biological activity and safety, as well as cost of goods. Risk-management developability assessments, introduced early on in development, can help identify and address potential causes of attrition in preclinical and clinical stages related to product manufacturing, safety, delivery and efficacy issues. This article discusses the utilization of in silico and in vitro surrogate assays early on in development as part of a comprehensive developability assessment for novel biotherapeutics, incorporating a closer interaction between discovery and development functions. It further suggests how such approaches can have a significant impact in streamlining drug development, delivering better and safer therapeutic candidates, while reducing risk and development costs.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Pharmaceutical Bioprocessing.
Article · 29 Nov 2025
Adaptive Bioprocess Control: Enabling Intelligent and Robust Biomanufacturing
Article · 29 Nov 2025
Advanced Foam Control Strategies in Bioprocessing
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Bioprocessing
- SubjectPharmaceutical Sciences
- SubjectBiochemistry & Biotechnology
- BylineArticles whose byline prints “Jesus Zurdo”
